These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9679953)

  • 21. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
    Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
    Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
    Tanney DC; Feng L; Pollock AS; Lovett DH
    Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.
    Ohnishi K; Takagi M; Kurokawa Y; Satomi S; Konttinen YT
    Lab Invest; 1998 Sep; 78(9):1077-87. PubMed ID: 9759652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion.
    Stearns ME; Rhim J; Wang M
    Clin Cancer Res; 1999 Jan; 5(1):189-96. PubMed ID: 9918218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
    Zhou CY; Yao JF; Chen XD
    Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact Co-cultures.
    Ko K; Yazumi S; Yoshikawa K; Konda Y; Nakajima M; Chiba T; Takahashi R
    Int J Cancer; 2000 Jul; 87(2):165-71. PubMed ID: 10861469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction.
    Ogura Y; Matsunaga Y; Nishiyama T; Amano S
    Br J Dermatol; 2008 Jul; 159(1):49-60. PubMed ID: 18460030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alendronate blocks TGF-beta1 stimulated collagen 1 degradation by human prostate PC-3 ML cells.
    Stearns ME
    Clin Exp Metastasis; 1998 May; 16(4):332-9. PubMed ID: 9626812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of bisphosphonate on the release of MMP-2 from cultured human osteoblasts.
    Ichinose Y; Migita K; Nakashima T; Kawakami A; Aoyagi T; Eguchi K
    Tohoku J Exp Med; 2000 Oct; 192(2):111-8. PubMed ID: 11211310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases.
    Quesada AR; Barbacid MM; Mira E; Fernández-Resa P; Márquez G; Aracil M
    Clin Exp Metastasis; 1997 Jan; 15(1):26-32. PubMed ID: 9009103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice.
    Stearns ME; Wang M
    Clin Exp Metastasis; 1998 Nov; 16(8):693-702. PubMed ID: 10211982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A: evidence for the existence of a low-affinity intermediate.
    Hutton M; Willenbrock F; Brocklehurst K; Murphy G
    Biochemistry; 1998 Jul; 37(28):10094-8. PubMed ID: 9665714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.
    Makowski GS; Ramsby ML
    Inflammation; 1998 Jun; 22(3):287-305. PubMed ID: 9604716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion.
    Ramos-DeSimone N; Hahn-Dantona E; Sipley J; Nagase H; French DL; Quigley JP
    J Biol Chem; 1999 May; 274(19):13066-76. PubMed ID: 10224058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinase-2 activation modulates glioma cell migration.
    Deryugina EI; Bourdon MA; Luo GX; Reisfeld RA; Strongin A
    J Cell Sci; 1997 Oct; 110 ( Pt 19)():2473-82. PubMed ID: 9410885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent.
    Teti A; Farina AR; Villanova I; Tiberio A; Tacconelli A; Sciortino G; Chambers AF; Gulino A; Mackay AR
    Int J Cancer; 1998 Jul; 77(1):82-93. PubMed ID: 9639398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Density-dependent regulation of cell-surface association of matrix metalloproteinase-2 (MMP-2) in breast-carcinoma cells.
    Menashi S; Dehem M; Souliac I; Legrand Y; Fridman R
    Int J Cancer; 1998 Jan; 75(2):259-65. PubMed ID: 9462717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.